
The global Synthetic Hormones market size is predicted to grow from US$ 228 million in 2025 to US$ 285 million in 2031; it is expected to grow at a CAGR of 3.7% from 2025 to 2031.
Synthetic hormones are foreign molecules that are produced in a laboratory and used to cure hormonal imbalances in men and women. Synthetic hormones such as progesterone, estrogen, thyroid hormone, testosterone, and insulin are commonly utilized to treat a variety of medical problems. These hormones are extremely active even at low doses, and long-term usage of synthetic hormones has been related to a variety of adverse effects. Some synthetic hormones on the market include Ferring B.V."s Zomacton injectable (Somatropin), which is used to treat growth hormone insufficiency in children.
The synthetic hormones market refers to the segment of the pharmaceutical industry that focuses on the development, production, and sale of synthetic or artificially produced hormones. Synthetic hormones are designed to mimic the effects of naturally occurring hormones in the body. Synthetic hormones play a crucial role in various medical treatments and therapies. They are used for a range of purposes, including hormone replacement therapy (HRT), contraception, fertility treatments, and management of hormonal disorders. Common synthetic hormones include estrogen, progesterone, testosterone, and various forms of birth control hormones. The market for synthetic hormones has witnessed significant growth in recent years due to several factors. One of the key drivers is the increasing prevalence of hormonal imbalances and disorders, such as menopause, polycystic ovary syndrome (PCOS), and hypogonadism. Additionally, the growing aging population and the increasing interest in anti-aging treatments have also contributed to the market expansion. Advancements in the field of biotechnology and pharmaceutical research have led to the development of advanced synthetic hormone formulations, including sustained-release formulations and combination therapies. These innovations offer improved efficacy, convenience, and patient compliance, further driving the market growth. The market is characterized by the presence of both generic and branded synthetic hormone products. Generic drugs are usually more affordable, leading to their widespread adoption, especially in developing regions. However, branded products continue to dominate the market in developed countries due to their brand recognition, marketing strategies, and perceived quality.
The “Synthetic Hormones Industry Forecast” looks at past sales and reviews total world Synthetic Hormones sales in 2024, providing a comprehensive analysis by region and market sector of projected Synthetic Hormones sales for 2025 through 2031. With Synthetic Hormones sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Synthetic Hormones industry.
This Insight Report provides a comprehensive analysis of the global Synthetic Hormones landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Synthetic Hormones portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Synthetic Hormones market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Synthetic Hormones and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Synthetic Hormones.
This report presents a comprehensive overview, market shares, and growth opportunities of Synthetic Hormones market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Steroid Hormones
Peptide Hormone
Amino Acid Derivatives
Segmentation by Application:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfizer, Inc.
McGuff Pharmaceuticals, Inc.
Lyndra Therapeutics, Inc.
Ferring B. V.
Slayback Pharma
Lupin Pharmaceuticals, Inc.
Acerus Pharmaceuticals Corporation
IBSA Institut Biochimique SA
Endo International plc
American Reagent, Inc.
Merck Serono
Novo Nordisk
F. Hoffmann-La Roche
BioPartners
Eli Lilly
Key Questions Addressed in this Report
What is the 10-year outlook for the global Synthetic Hormones market?
What factors are driving Synthetic Hormones market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Synthetic Hormones market opportunities vary by end market size?
How does Synthetic Hormones break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Synthetic Hormones Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Synthetic Hormones by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Synthetic Hormones by Country/Region, 2020, 2024 & 2031
2.2 Synthetic Hormones Segment by Type
2.2.1 Steroid Hormones
2.2.2 Peptide Hormone
2.2.3 Amino Acid Derivatives
2.3 Synthetic Hormones Sales by Type
2.3.1 Global Synthetic Hormones Sales Market Share by Type (2020-2025)
2.3.2 Global Synthetic Hormones Revenue and Market Share by Type (2020-2025)
2.3.3 Global Synthetic Hormones Sale Price by Type (2020-2025)
2.4 Synthetic Hormones Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Synthetic Hormones Sales by Application
2.5.1 Global Synthetic Hormones Sale Market Share by Application (2020-2025)
2.5.2 Global Synthetic Hormones Revenue and Market Share by Application (2020-2025)
2.5.3 Global Synthetic Hormones Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Synthetic Hormones Breakdown Data by Company
3.1.1 Global Synthetic Hormones Annual Sales by Company (2020-2025)
3.1.2 Global Synthetic Hormones Sales Market Share by Company (2020-2025)
3.2 Global Synthetic Hormones Annual Revenue by Company (2020-2025)
3.2.1 Global Synthetic Hormones Revenue by Company (2020-2025)
3.2.2 Global Synthetic Hormones Revenue Market Share by Company (2020-2025)
3.3 Global Synthetic Hormones Sale Price by Company
3.4 Key Manufacturers Synthetic Hormones Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Synthetic Hormones Product Location Distribution
3.4.2 Players Synthetic Hormones Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Synthetic Hormones by Geographic Region
4.1 World Historic Synthetic Hormones Market Size by Geographic Region (2020-2025)
4.1.1 Global Synthetic Hormones Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Synthetic Hormones Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Synthetic Hormones Market Size by Country/Region (2020-2025)
4.2.1 Global Synthetic Hormones Annual Sales by Country/Region (2020-2025)
4.2.2 Global Synthetic Hormones Annual Revenue by Country/Region (2020-2025)
4.3 Americas Synthetic Hormones Sales Growth
4.4 APAC Synthetic Hormones Sales Growth
4.5 Europe Synthetic Hormones Sales Growth
4.6 Middle East & Africa Synthetic Hormones Sales Growth
5 Americas
5.1 Americas Synthetic Hormones Sales by Country
5.1.1 Americas Synthetic Hormones Sales by Country (2020-2025)
5.1.2 Americas Synthetic Hormones Revenue by Country (2020-2025)
5.2 Americas Synthetic Hormones Sales by Type (2020-2025)
5.3 Americas Synthetic Hormones Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Synthetic Hormones Sales by Region
6.1.1 APAC Synthetic Hormones Sales by Region (2020-2025)
6.1.2 APAC Synthetic Hormones Revenue by Region (2020-2025)
6.2 APAC Synthetic Hormones Sales by Type (2020-2025)
6.3 APAC Synthetic Hormones Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Synthetic Hormones by Country
7.1.1 Europe Synthetic Hormones Sales by Country (2020-2025)
7.1.2 Europe Synthetic Hormones Revenue by Country (2020-2025)
7.2 Europe Synthetic Hormones Sales by Type (2020-2025)
7.3 Europe Synthetic Hormones Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Synthetic Hormones by Country
8.1.1 Middle East & Africa Synthetic Hormones Sales by Country (2020-2025)
8.1.2 Middle East & Africa Synthetic Hormones Revenue by Country (2020-2025)
8.2 Middle East & Africa Synthetic Hormones Sales by Type (2020-2025)
8.3 Middle East & Africa Synthetic Hormones Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Synthetic Hormones
10.3 Manufacturing Process Analysis of Synthetic Hormones
10.4 Industry Chain Structure of Synthetic Hormones
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Synthetic Hormones Distributors
11.3 Synthetic Hormones Customer
12 World Forecast Review for Synthetic Hormones by Geographic Region
12.1 Global Synthetic Hormones Market Size Forecast by Region
12.1.1 Global Synthetic Hormones Forecast by Region (2026-2031)
12.1.2 Global Synthetic Hormones Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Synthetic Hormones Forecast by Type (2026-2031)
12.7 Global Synthetic Hormones Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Pfizer, Inc.
13.1.1 Pfizer, Inc. Company Information
13.1.2 Pfizer, Inc. Synthetic Hormones Product Portfolios and Specifications
13.1.3 Pfizer, Inc. Synthetic Hormones Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer, Inc. Main Business Overview
13.1.5 Pfizer, Inc. Latest Developments
13.2 McGuff Pharmaceuticals, Inc.
13.2.1 McGuff Pharmaceuticals, Inc. Company Information
13.2.2 McGuff Pharmaceuticals, Inc. Synthetic Hormones Product Portfolios and Specifications
13.2.3 McGuff Pharmaceuticals, Inc. Synthetic Hormones Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 McGuff Pharmaceuticals, Inc. Main Business Overview
13.2.5 McGuff Pharmaceuticals, Inc. Latest Developments
13.3 Lyndra Therapeutics, Inc.
13.3.1 Lyndra Therapeutics, Inc. Company Information
13.3.2 Lyndra Therapeutics, Inc. Synthetic Hormones Product Portfolios and Specifications
13.3.3 Lyndra Therapeutics, Inc. Synthetic Hormones Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Lyndra Therapeutics, Inc. Main Business Overview
13.3.5 Lyndra Therapeutics, Inc. Latest Developments
13.4 Ferring B. V.
13.4.1 Ferring B. V. Company Information
13.4.2 Ferring B. V. Synthetic Hormones Product Portfolios and Specifications
13.4.3 Ferring B. V. Synthetic Hormones Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Ferring B. V. Main Business Overview
13.4.5 Ferring B. V. Latest Developments
13.5 Slayback Pharma
13.5.1 Slayback Pharma Company Information
13.5.2 Slayback Pharma Synthetic Hormones Product Portfolios and Specifications
13.5.3 Slayback Pharma Synthetic Hormones Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Slayback Pharma Main Business Overview
13.5.5 Slayback Pharma Latest Developments
13.6 Lupin Pharmaceuticals, Inc.
13.6.1 Lupin Pharmaceuticals, Inc. Company Information
13.6.2 Lupin Pharmaceuticals, Inc. Synthetic Hormones Product Portfolios and Specifications
13.6.3 Lupin Pharmaceuticals, Inc. Synthetic Hormones Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Lupin Pharmaceuticals, Inc. Main Business Overview
13.6.5 Lupin Pharmaceuticals, Inc. Latest Developments
13.7 Acerus Pharmaceuticals Corporation
13.7.1 Acerus Pharmaceuticals Corporation Company Information
13.7.2 Acerus Pharmaceuticals Corporation Synthetic Hormones Product Portfolios and Specifications
13.7.3 Acerus Pharmaceuticals Corporation Synthetic Hormones Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Acerus Pharmaceuticals Corporation Main Business Overview
13.7.5 Acerus Pharmaceuticals Corporation Latest Developments
13.8 IBSA Institut Biochimique SA
13.8.1 IBSA Institut Biochimique SA Company Information
13.8.2 IBSA Institut Biochimique SA Synthetic Hormones Product Portfolios and Specifications
13.8.3 IBSA Institut Biochimique SA Synthetic Hormones Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 IBSA Institut Biochimique SA Main Business Overview
13.8.5 IBSA Institut Biochimique SA Latest Developments
13.9 Endo International plc
13.9.1 Endo International plc Company Information
13.9.2 Endo International plc Synthetic Hormones Product Portfolios and Specifications
13.9.3 Endo International plc Synthetic Hormones Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Endo International plc Main Business Overview
13.9.5 Endo International plc Latest Developments
13.10 American Reagent, Inc.
13.10.1 American Reagent, Inc. Company Information
13.10.2 American Reagent, Inc. Synthetic Hormones Product Portfolios and Specifications
13.10.3 American Reagent, Inc. Synthetic Hormones Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 American Reagent, Inc. Main Business Overview
13.10.5 American Reagent, Inc. Latest Developments
13.11 Merck Serono
13.11.1 Merck Serono Company Information
13.11.2 Merck Serono Synthetic Hormones Product Portfolios and Specifications
13.11.3 Merck Serono Synthetic Hormones Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Merck Serono Main Business Overview
13.11.5 Merck Serono Latest Developments
13.12 Novo Nordisk
13.12.1 Novo Nordisk Company Information
13.12.2 Novo Nordisk Synthetic Hormones Product Portfolios and Specifications
13.12.3 Novo Nordisk Synthetic Hormones Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Novo Nordisk Main Business Overview
13.12.5 Novo Nordisk Latest Developments
13.13 F. Hoffmann-La Roche
13.13.1 F. Hoffmann-La Roche Company Information
13.13.2 F. Hoffmann-La Roche Synthetic Hormones Product Portfolios and Specifications
13.13.3 F. Hoffmann-La Roche Synthetic Hormones Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 F. Hoffmann-La Roche Main Business Overview
13.13.5 F. Hoffmann-La Roche Latest Developments
13.14 BioPartners
13.14.1 BioPartners Company Information
13.14.2 BioPartners Synthetic Hormones Product Portfolios and Specifications
13.14.3 BioPartners Synthetic Hormones Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 BioPartners Main Business Overview
13.14.5 BioPartners Latest Developments
13.15 Eli Lilly
13.15.1 Eli Lilly Company Information
13.15.2 Eli Lilly Synthetic Hormones Product Portfolios and Specifications
13.15.3 Eli Lilly Synthetic Hormones Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Eli Lilly Main Business Overview
13.15.5 Eli Lilly Latest Developments
14 Research Findings and Conclusion
*If Applicable.
